Background
==========

Liver cirrhosis is one of the most common causes of death in the world \[[@b1-medscimonit-21-3961],[@b2-medscimonit-21-3961]\]. Natural history of liver cirrhosis is primarily divided into four stages \[[@b3-medscimonit-21-3961],[@b4-medscimonit-21-3961]\]. Stage 1, 2, 3, and 4 are characterized respectively by neither varices nor ascites, varices without ascites or bleeding, ascites with or without varices, and variceal bleeding with or without ascites, respectively. The prognosis is gradually worsened with increased stage of liver cirrhosis. Notably, the mortality is 3.4% per year in patients with varices who have never bled. By comparison, the mortality is up to 57% per year in patients with variceal bleeding. Thus, early diagnosis of varices and primary prophylaxis of variceal bleeding in high-risk patients with liver cirrhosis should be actively employed \[[@b5-medscimonit-21-3961],[@b6-medscimonit-21-3961]\].

Upper gastrointestinal endoscopy is the golden diagnostic test of varices in liver cirrhosis. However, because of its invasiveness and discomfort, most of patients are reluctant to undergo this procedure. Recently, numerous non-invasive markers of varices have been explored in patients with liver cirrhosis \[[@b7-medscimonit-21-3961]--[@b9-medscimonit-21-3961]\]. However, they may be rarely used in clinical practices \[[@b10-medscimonit-21-3961]\]. Herein, we aimed to evaluate the diagnostic accuracy of aspartate aminotransferase (AST) to platelet (PLT) ratio index (i.e., APRI), AST to alanine aminotransferase (ALT) ratio (i.e., AAR), FIB-4, fibrosis index (FI), and King scores in predicting the presence of varices and high-risk varices in liver cirrhosis. These non-invasive scores were selected, because they were readily available from regular laboratory tests and demographic data \[[@b11-medscimonit-21-3961]--[@b15-medscimonit-21-3961]\].

Material and Methods
====================

Study design
------------

All patients who were consecutively admitted to our hospital between January 2012 and June 2014 were considered in this retrospective study. The inclusion criteria were as follows: 1) patients were diagnosed with liver cirrhosis; 2) patients underwent both laboratory tests and endoscopic examinations. The exclusion criteria were as follows: 1) patients were diagnosed with malignant tumors; 2) patients did not undergo endoscopic examinations to evaluate the presence and degree of esophageal varices (EVs); and 3) the relevant laboratory data were missing. Notably, repeated admissions were not excluded. In other words, if one patient underwent endoscopy two or more times at different admissions during the enrollment period, all results would be included in our study. This was primarily because we just observed the association between non-invasive scores and varices. Some data had been reported in our previous papers \[[@b16-medscimonit-21-3961]--[@b19-medscimonit-21-3961]\]. This study was approved by the Ethics Committee of our hospital (number k(2015)11). Due to the retrospective nature of this study, patient written informed consents were waived.

Data collection
---------------

We collected the following data from electronic medical records: age, sex, etiology of liver diseases, ascites, hepatic encephalopathy (HE), history of upper gastrointestinal bleeding (UGIB), history of splenectomy, endoscopic findings, red blood cell (RBC), hemoglobin (Hb), white blood cell (WBC), PLT, ALT, AST, prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), albumin (ALB), total bilirubin (TBIL), alkaline phosphatase (ALP), γ-glutamine transferase (GGT) and creatinine (Cr). Additionally, we calculated the Child-Pugh \[[@b20-medscimonit-21-3961]\], model for end-stage of liver disease (MELD) \[[@b21-medscimonit-21-3961]\], APRI \[[@b11-medscimonit-21-3961]\], AAR \[[@b12-medscimonit-21-3961]\], FIB-4 \[[@b13-medscimonit-21-3961]\], FI \[[@b14-medscimonit-21-3961]\], and King scores \[[@b15-medscimonit-21-3961]\].

1.  Child-Pugh score = ALB score + TBIL score + INR score + ascites score + HE score

2.  MELD score = 9.57x ln(Cr) + 3.78 × ln(TBIL) + 11.2 × ln (INR) + 6.43

3.  APRI = \[(AST/ULN) × 100\]/PLT

4.  AAR = AST/ALT

5.  FIB-4 = (age^\*^AST)/PLT^\*^ALT^1/2^

6.  FI = 8--0.01^\*^PLT-ALB

7.  King = age^\*^AST^\*^INR/PLT

Evaluation of EVs
-----------------

Grade of EVs was classified into no, mild, moderate, and severe according to the 2008 Hangzhou consensus, which was proposed by the Chinese Society of Gastroenterology, Chinese Society of Hepatology, and Chinese Society of Digestive Endoscopy \[[@b22-medscimonit-21-3961]\]. This classification is widely employed in China and is primarily based on the general rules by Japanese Society for Portal Hypertension, Baveno consensus, AASLD practice guidelines, and clinical practices in China \[[@b5-medscimonit-21-3961],[@b6-medscimonit-21-3961],[@b23-medscimonit-21-3961]\]. We re-evaluated the grade of EVs by reviewing the original medical records and endoscopic results. Gastric varices were not considered in this study. Before the statistical analysis, we were blind to the correlation of EVs with non-invasive scores.

Statistical analysis
--------------------

Categorical data were expressed as frequencies (percentages) and compared by using the chi-square tests. Continuous data were expressed as mean ± standard deviation and compared by using the independent sample t-tests. Receiver operating characteristic (ROC) curves were performed to evaluate and compare the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores for the prediction of EVs (moderate-severe versus no-mild EVs; with versus without EVs). The diagnostic performances were expressed as area under curve (AUC), sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value. AUCs were compared by using DeLong test. Optimal cut-off values were chosen while the sum of sensitivity and specificity would be maximal. Subgroup analysis was performed in patients without any previous history of UGIB, in those with Child-Pugh class A or B+C, and in those without any previous history of splenectomy. A two-sided P\<0.05 was considered statistically significant. All statistical analyses were performed by using the SPSS software version 18.0 (SPSS Inc. Chicago, IL, USA).

Results
=======

Patients
--------

Overall, 650 patients were eligible in our study. The characteristics of all patients are shown in [Table 1](#t1-medscimonit-21-3961){ref-type="table"}. Among them, 81.4% had moderate-severe EVs, 81.8% had previous history of UGIB, and 52.6% had Child-Pugh classes B and C.

Overall analysis
----------------

### Moderate-severe versus no-mild EVs

Compared with the no-mild EVs group, the moderate-severe EVs group had significantly higher proportions of ascites and history of UGIB, significantly higher PT, INR, Child-Pugh score, and FI score, but significantly lower RBC, Hb, PLT, ALB, ALT, and GGT ([Table 1](#t1-medscimonit-21-3961){ref-type="table"}).

FI score had the largest AUC (AUC=0.6), followed by FIB-4 (AUC=0.544), AAR (AUC=0.538), King (AUC=0.526), and APRI scores (AUC=0.506) ([Figure 1A](#f1-medscimonit-21-3961){ref-type="fig"}). AUC of FI score was not significantly different from that of FIB-4 (P=0.1041) or AAR score (P=0.0892), but was significantly larger than that of King (P=0.0293) and APRI scores (P=0.0093).

### With versus without EVs

Compared with the no EVs group, the EVs group had significantly higher proportions of male, ascites, history of UGIB, and Child-Pugh class B+C, significantly higher PT, INR, Child-Pugh score, and FI score, but significantly lower RBC, Hb, PLT, ALB, ALT, and GGT ([Table 1](#t1-medscimonit-21-3961){ref-type="table"}).

FI score had the largest AUC (AUC=0.612), followed by FIB-4 (AUC=0.567), AAR (AUC=0.56), King (AUC=0.55), and APRI scores (AUC=0.539) ([Figure 1B](#f1-medscimonit-21-3961){ref-type="fig"}). AUC of FI score was not significantly different from that of FIB-4 (P=0.2510), AAR (P=0.2167), King (P=0.1144), or APRI score (P=0.0873).

Subgroup analysis in patients without UGIB
------------------------------------------

### Moderate-severe versus no-mild EVs

Compared with the no-mild EVs group, the moderate-severe EVs group had significantly higher FIB-4 and FI scores, but significantly lower PLT and ALB ([Table 2](#t2-medscimonit-21-3961){ref-type="table"}).

FIB-4 score had the largest AUC (AUC=0.664), followed by King (AUC=0.645), FI (AUC=0.636), APRI (AUC=0.627), and AAR scores (AUC=0.601) ([Figure 2A](#f2-medscimonit-21-3961){ref-type="fig"}). AUC of FIB-4 score was not significantly different from that of FI (P=0.6317), King (P=0.3537), AAR (P=0.3037), or APRI score (P=0.1571).

### With versus without EVs

Compared with the no EVs group, the EVs group had significantly higher PT, APTT, INR, FIB-4 score, and FI score, but significantly lower PLT and ALB ([Table 2](#t2-medscimonit-21-3961){ref-type="table"}).

FI score had the largest AUC (AUC=0.662), followed by FIB-4 (AUC=0.655), King (AUC=0.639), APRI (AUC=0.634), and AAR scores (AUC=0.596) ([Figure 2B](#f2-medscimonit-21-3961){ref-type="fig"}). The AUC of FI score was not significantly different from that of FIB-4 (P=0.9120), King (P=0.6968), APRI (P=0.6530), or AAR score (P=0.3083).

Subgroup analysis in patients without UGIB at Child-Pugh class A
----------------------------------------------------------------

### Moderate-severe versus no-mild EVs

Compared with the no-mild EVs group, the moderate-severe EVs group had significantly higher PT and INR, but a significantly lower WBC ([Table 3](#t3-medscimonit-21-3961){ref-type="table"}).

FIB-4 score had the largest AUC (AUC=0.649), followed by King (AUC=0.629), APRI (AUC=0.611), FI (AUC=0.589), and AAR scores (AUC=0.549) ([Figure 3A](#f3-medscimonit-21-3961){ref-type="fig"}). AUC of FIB-4 score was not significantly different from that of King (P=0.5172), FI (P=0.4906), APRI (P=0.3419), or AAR score (P=0.3025).

### With versus without EVs

Compared with the no EVs group, the EVs group had a significantly lower WBC ([Table 3](#t3-medscimonit-21-3961){ref-type="table"}).

FIB-4 score had the largest AUC (AUC=0.638), followed by King (AUC=0.62), APRI (AUC=0.608), FI (AUC=0.588), and AAR scores (AUC=0.524) ([Figure 3B](#f3-medscimonit-21-3961){ref-type="fig"}). The AUC of FIB-4 score was not significantly different from that of FI (P=0.5732), King (P=0.5542), APRI (P=0.4411), or AAR score (P=0.2463).

Subgroup analysis in patients without UGIB at Child-Pugh class B and C
----------------------------------------------------------------------

### Moderate-severe versus no-mild EVs

Compared with the no-mild EVs group, the moderate-severe EVs group had a significantly higher FI score, but significantly lower PLT and ALB ([Table 4](#t4-medscimonit-21-3961){ref-type="table"}).

FIB-4 score had the largest AUC (AUC=0.674), followed by FI (AUC=0.643), King (AUC=0.63), AAR (AUC=0.62), and APRI scores (AUC=0.618) ([Figure 4A](#f4-medscimonit-21-3961){ref-type="fig"}). The AUC of FIB-4 score was not significantly different from that of FI (P=0.7411), AAR (P=0.5294), King (P=0.2340), or APRI score (P=0.1717).

### With versus without EVs

Compared with the no EVs group, the EVs group had a significantly higher FI score, but significantly lower PLT and ALB ([Table 4](#t4-medscimonit-21-3961){ref-type="table"}).

FI score had the largest AUC (AUC=0.68), followed by FIB-4 (AUC=0.659), APRI (AUC=0.617), King (AUC=0.61), and AAR scores (AUC=0.605) ([Figure 4B](#f4-medscimonit-21-3961){ref-type="fig"}). The AUC of FI score was not significantly different from that of FIB-4 (P=0.8261), APRI (P=0.5687), King (P=0.5217), or AAR score (P=0.5058).

Subgroup analysis in patients without UGIB or splenectomy
---------------------------------------------------------

### Moderate-severe versus no-mild EVs

Compared with the no-mild EVs group, moderate-severe EVs group had significantly higher FIB-4 and FI scores, but significantly lower PLT and ALB ([Table 5](#t5-medscimonit-21-3961){ref-type="table"}).

FIB-4 score had the largest AUC (AUC=0.69), followed by FI and King (AUC=0.66 for both of them), APRI (AUC=0.651), and AAR scores (AUC=0.627) ([Figure 5A](#f5-medscimonit-21-3961){ref-type="fig"}). The AUC of FIB-4 score was not significantly different from that of FI (P=0.6041), AAR (P=0.2949), APRI (P=0.1353), or King score (P=0.1330).

### With versus without EVs

Compared with the no EVs group, the EVs group had significantly higher FIB-4 and FI scores, but significantly lower WBC, PLT, and ALB ([Table 5](#t5-medscimonit-21-3961){ref-type="table"}).

FIB-4 score had the largest AUC (AUC=0.692), followed by FI (AUC=0.67), King (AUC=0.662), APRI (AUC=0.654), and AAR scores (AUC=0.607) ([Figure 5B](#f5-medscimonit-21-3961){ref-type="fig"}). The AUC of FIB-4 score was not significantly different from that of FI (P=0.7167), AAR (P=0.1783), APRI (P=0.1578), or King score (P=0.1423).

Discussion
==========

Non-invasive markers of varices are primarily derived from non-invasive assessment of liver fibrosis. For example, APRI was first developed by Wai and colleagues to identify the presence of significant fibrosis and liver cirrhosis in patients with chronic hepatitis C \[[@b11-medscimonit-21-3961]\]. Similarly, AAR, FIB-4, FI, and King scores were originally used for the assessment of liver fibrosis and its severity in patients with hepatitis C \[[@b12-medscimonit-21-3961]--[@b15-medscimonit-21-3961]\]. More importantly, they were calculated based on some regular laboratory data (i.e., AST, ALT, ALB, INR, and PLT). By comparison, several other non-invasive markers might not be easily accessible, such as Forns' index (composed of age, GGT, cholesterol, and PLT \[[@b24-medscimonit-21-3961]\]), Fibrometer (composed of PLT, prothrombin index, AST, alpha-2 macroglobulin, hyaluronate, urea, and age \[[@b25-medscimonit-21-3961]\]), and Hepascore (composed of bilirubin, GGT, hyaluronic acid, alpha-2 macroglobulin, age, and sex) \[[@b26-medscimonit-21-3961]\]. Indeed, cholesterol, hyaluronic acid or hyaluronate, and alpha-2 macroglobulin are not detected in our everyday clinical practices, although our recent study has explored the predictive role of four major serum liver fibrosis markers, including hyaluronic acid, laminin, amino-terminal propeptide of type III procollagen, and collagen IV, for predicting the presence of gastroesophageal varices in 118 patients with liver cirrhosis \[[@b16-medscimonit-21-3961]\]. Thus, only APRI, AAR, FIB-4, FI, and King scores, rather than Forns' index, Fibrometer, or Hepascore, were evaluated in the present study.

The characteristics of our study population should be noted, as follows.

First, considering that a valid score can be generalized for any clinical conditions, all cirrhotic patients undergoing endoscopic examinations should be eligible for our study.

Second, the history of UGIB was not restricted in the overall analysis. Because not all episodes of acute UGIB were attributed to the varices in patients with liver cirrhosis \[[@b27-medscimonit-21-3961]\], we should also identify whether the source of acute UGIB was from varices, peptic ulcer, or others. Indeed, this was important and helpful in choosing the appropriate drugs.

Third, moderate and severe EVs were ascribed to one group, because the treatment strategy was similar in both of them \[[@b5-medscimonit-21-3961]\].

Fourth, in our study, only a very low proportion of patients presented with grade I--II hepatic encephalopathy at their admissions, and none of them presented with grade III--IV hepatic encephalopathy. This could be because patients must be clearly conscious during upper gastrointestinal endoscopic examinations.

Our study demonstrated that the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores was modest. These findings were largely consistent with the results of our recent meta-analysis (PROSPERO registration number: CRD42015017519) \[[@b28-medscimonit-21-3961]\]. Additionally, it appeared that FIB-4 and FI scores had better diagnostic accuracy than other non-invasive scores. However, their diagnostic accuracy was not significantly different among most comparative analyses.

Our study also showed that the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores might be gradually improved as the study population was further refined ([Figure 6](#f6-medscimonit-21-3961){ref-type="fig"}). These findings suggested that candidates undergoing non-invasive assessment of varices should be appropriately selected. Indeed, if there was a history of splenectomy in a patient with liver cirrhosis, the PLT would remarkably increase and then return back to a normal level \[[@b29-medscimonit-21-3961]\]. In this setting, the association of PLT with portal hypertension would be also masked, thereby weakening the diagnostic accuracy of non-invasive scores which include PLT.

Except for the retrospective nature, it should be acknowledged that a majority of patients undergoing endoscopic examinations had positive EVs in our study. This phenomenon might be primarily because most of our patients were at a more advanced stage or had decompensated cirrhosis and our physicians preferred to prescribe the endoscopy to patients with more severe liver cirrhosis. Given the potential bias of patient selection, the eligibility criteria should be refined in further prospective studies.

Conclusions
===========

APRI, AAR, FIB-4, FI, and King scores had modest diagnostic accuracy for varices in liver cirrhosis. It would be difficult to replace the use of upper gastrointestinal endoscopy for the diagnosis of varices by these non-invasive scores. In future, an optimal non-invasive score should be established and validated in prospective multicenter studies.
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![Receiver operating characteristic curves showing the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores in predicting the presence of varices in liver cirrhosis. (**A**) Prediction of moderate-severe varices. (**B**) Prediction of varices. AUC -- area under curve; PLR -- positive likelihood ratio; PPV -- positive predictive value; NLR -- negative likelihood ratio; NPV -- negative predictive value; Sen -- sensitivity; Spec -- specificity.](medscimonit-21-3961-g001){#f1-medscimonit-21-3961}

![Receiver operating characteristic curves showing the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores in predicting the presence of varices in liver cirrhosis without UGIB. (**A**) Prediction of moderate-severe varices. (**B**) Prediction of varices. AUC -- area under curve; PLR -- positive likelihood ratio; PPV -- positive predictive value; NLR -- negative likelihood ratio; NPV -- negative predictive value; Sen -- sensitivity; Spec -- specificity.](medscimonit-21-3961-g002){#f2-medscimonit-21-3961}

![Receiver operating characteristic curves showing the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores in predicting the presence of varices in liver cirrhosis without UGIB at Child-Pugh class A. (**A**) Prediction of moderate-severe varices. (**B**) Prediction of varices. AUC -- area under curve; PLR -- positive likelihood ratio; PPV -- positive predictive value; NLR -- negative likelihood ratio; NPV -- negative predictive value; Sen -- sensitivity; Spec -- specificity.](medscimonit-21-3961-g003){#f3-medscimonit-21-3961}

![Receiver operating characteristic curves showing the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores in predicting the presence of varices in liver cirrhosis without UGIB at Child-Pugh classes B and C. (**A**) Prediction of moderate-severe varices. (**B**) Prediction of varices. AUC -- area under curve; PLR -- positive likelihood ratio; PPV -- positive predictive value; NLR -- negative likelihood ratio; NPV -- negative predictive value; Sen -- sensitivity; Spec -- specificity.](medscimonit-21-3961-g004){#f4-medscimonit-21-3961}

![Receiver operating characteristic curves showing the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores in predicting the presence of varices in liver cirrhosis without UGIB or splenectomy. (**A**) Prediction of moderate-severe varices. (**B**) Prediction of varices. AUC -- area under curve; PLR -- positive likelihood ratio; PPV -- positive predictive value; NLR -- negative likelihood ratio; NPV -- negative predictive value; Sen -- sensitivity; Spec -- specificity.](medscimonit-21-3961-g005){#f5-medscimonit-21-3961}

![Areas under curves showing the diagnostic accuracy of APRI, AAR, FIB-4, FI, and King scores in different study populations. (**A**) Prediction of moderate-severe varices. (**B**) Prediction of varices.](medscimonit-21-3961-g006){#f6-medscimonit-21-3961}

###### 

Overall analysis.

  Variables                                Total Pts (n=650)   Moderate-large varices Pts (n=529)   No-mild varices Pts (n=121)   P value       With varices Pts (n=557)   Without varices Pts (n=93)   P value
  ---------------------------------------- ------------------- ------------------------------------ ----------------------------- ------------- -------------------------- ---------------------------- -------------
  Sex (male/female)                        425/225             353/176                              72/49                         0.132         373/184                    52/41                        **0.038**
  Age (years)                              53.54±11.75         53.61±11.82                          53.27±11.48                   0.774         53.38±11.85                54.51±11.14                  0.393
  Etiology of liver diseases, n (%)                                                                                               0.396                                                                 0.386
   Hepatitis B virus                       199 (30.6)          169 (31.9)                           30 (24.8)                                   176 (31.6)                 23 (24.7)                    
   Hepatitis C virus                       46 (7.1)            38 (7.2)                             8 (6.6)                                     39 (7.0)                   7 (7.5)                      
   Hepatitis B virus + Hepatitis C virus   5 (0.8)             5 (0.9)                              0 (0)                                       5 (0.9)                    0 (0)                        
   Alcohol                                 154 (23.7)          119 (22.5)                           35 (28.9)                                   128 (23.0)                 26 (28.0)                    
   Hepatitis B virus + Alcohol             47 (7.2)            40 (7.6)                             7 (5.8)                                     41 (7.4)                   6 (6.5)                      
   Unknown                                 122 (18.8)          91 (17.2)                            31 (25.6)                                   97 (17.4)                  25 (26.9)                    
   Others                                  77 (11.8)           67 (12.7)                            10 (8.3)                                    71 (12.7)                  6 (6.5)                      
  Ascites, n (%)                                                                                                                  **0.029**                                                             **0.007**
   No                                      364 (56.0)          284 (53.7)                           80 (66.1)                                   298 (53.5)                 66 (71.0)                    
   Mild                                    91 (14.0)           75 (14.2)                            16 (13.2)                                   83 (14.9)                  8 (8.6)                      
   Moderate to severe                      195 (30.0)          170 (32.1)                           25 (20.7)                                   176 (31.6)                 19 (20.4)                    
  Hepatic encephalopathy, n (%)                                                                                                   0.676                                                                 0.491
   No                                      637 (98.0)          519 (98.1)                           118 (97.5)                                  545 (97.8)                 92 (98.9)                    
   Grade I--II                             13 (2.0)            10 (1.9)                             3 (2.5)                                     12 (2.2)                   1 (1.1)                      
   Grade III--IV                           0 (0)               0 (0)                                0 (0)                                       0 (0)                      0 (0)                        
  History of UGIB (yes/no)                 532/118             467/62                               65/56                         **\<0.001**   489/68                     43/50                        **\<0.001**
  Varices, n (%)                                                                                                                  NA                                                                    NA
   No                                      93 (14.3)           0 (0)                                93 (76.9)                                   0 (0)                      93 (100)                     
   Mild                                    28 (4.3)            0 (0)                                28 (23.1)                                   28 (5.0)                   0 (0)                        
   Moderate                                78 (12.0)           78 (14.7)                            0 (0)                                       78 (14.0)                  0 (0)                        
   Severe                                  451 (69.4)          451 (85.3)                           0 (0)                                       451 (81.0)                 0 (0)                        
  Laboratory tests                                                                                                                                                                                      
   RBC                                     3.04±0.79           2.96±0.75                            3.37±0.88                     **\<0.001**   2.99±0.75                  3.32±0.95                    **\<0.001**
   Hb                                      86.50±27.44         83.38±25.61                          100.16±30.91                  **\<0.001**   84.23±25.58                100.13±33.71                 **\<0.001**
   WBC                                     4.43±3.08           4.33±3.02                            4.90±3.30                     0.065         4.34±3.01                  4.99±3.41                    0.059
   PLT                                     98.20±87.98         94.94±87.34                          112.43±89.72                  **0.049**     94.88±86.72                118.05±93.27                 **0.019**
   TBIL                                    26.25±29.22         25.30±26.60                          30.40±38.54                   0.084         25.84±26.74                28.72±41.20                  0.38
   DBIL                                    12.92±21.12         12.18±18.92                          16.15±28.72                   0.062         12.51±18.92                15.37±31.23                  0.227
   IBIL                                    13.27±10.68         13.08±10.32                          14.08±12.14                   0.353         13.27±10.35                13.24±12.52                  0.979
   ALB                                     33.21±6.36          32.80±6.38                           34.98±6.00                    **0.001**     32.86±6.33                 35.30±6.20                   **0.001**
   ALT                                     34.30±57.40         31.07±27.93                          48.42±118.91                  **0.003**     31.20±27.63                52.87±135.00                 **0.001**
   AST                                     48.36±78.81         46.09±78.86                          58.31±78.14                   0.124         46.47±77.33                59.71±86.68                  0.134
   ALP                                     100.37±85.17        97.68±83.63                          112.17±91.06                  0.091         98.79±84.73                109.89±87.62                 0.245
   GGT                                     95.05±235.38        77.22±135.85                         173.01±459.24                 **\<0.001**   81.82±145.57               174.29±505.32                **\<0.001**
   BUN                                     6.55±4.21           6.66±4.32                            6.06±3.63                     0.154         6.63±4.25                  6.10±3.93                    0.262
   Cr                                      62.29±40.95         61.88±37.85                          64.10±52.54                   0.591         61.60±37.11                66.45±59.04                  0.291
   PT                                      16.02±3.45          16.17±3.50                           15.36±3.13                    **0.019**     16.17±3.46                 15.14±3.27                   **0.008**
   APTT                                    41.93±8.82          41.95±9.21                           41.85±6.90                    0.907         42.05±9.12                 41.21±6.70                   0.396
   INR                                     1.30±0.39           1.31±0.39                            1.23±0.34                     **0.021**     1.31±0.39                  1.20±0.35                    **0.01**
  Child-Pugh class, n (%)                                                                                                         0.062                                                                 **0.012**
   A                                       308 (47.4)          239 (45.2)                           69 (57.0)                                   251 (45.1)                 57 (61.3)                    
   B                                       279 (42.9)          237 (44.8)                           42 (34.7)                                   248 (44.5)                 31 (33.3)                    
   C                                       63 (9.7)            53 (10.0)                            10 (8.3)                                    58 (10.4)                  5 (5.4)                      
  Child-Pugh score                         6.60±1.76           7.03±1.76                            6.64±1.72                     **0.027**     7.04±1.78                  6.45±1.54                    **0.003**
  MELD score                               5.07±5.72           5.18±5.61                            4.59±6.18                     0.301         5.22±5.59                  4.20±6.44                    0.114
  APRI score                               2.15±3.88           2.15±4.11                            2.15±2.60                     1             2.16±4.03                  2.09±2.80                    0.864
  AAR score                                1.51±0.69           1.51±0.68                            1.51±0.74                     0.897         1.52±0.68                  1.48±0.76                    0.564
  FIB-4 score                              6.61±7.17           6.71±7.44                            6.15±5.86                     0.444         6.74±7.36                  5.81±5.94                    0.25
  FI score                                 −26.19±6.53         −25.75±6.54                          −28.10±6.18                   **\<0.001**   −25.81±6.48                −28.48±6.40                  **\<0.001**
  King score                               61.17±213.86        63.56±235.06                         50.74±64.08                   0.552         63.21±229.33               48.99±67.93                  0.553

AAR -- AST to ALT ratio; ALB -- albumin; ALP -- alkaline phosphatase; ALT -- alanine aminotransferase; APRI -- AST to platelets ratio index; APTT -- activated partial thromboplastin time; AST -- aspartate aminotransferase; AUC -- area under curve; BUN -- blood urea nitrogen; Cr -- creatinine; DBIL -- direct bilirubin; FI -- fibrosis index; FIB-4 -- fibrosis 4 index; GGT -- gamma-glutamyl transpeptidase; Hb -- hemoglobin; IBIL -- indirect bilirubin; INR -- international normalized ratio; MELD -- model for end stage liver disease; NA -- not available; PLT -- platelet; PT -- prothrombin time; Pts -- patients; RBC -- red blood cell; TBIL -- total bilirubin; UGIB -- upper gastrointestinal bleeding; WBC -- white blood cell.

###### 

Subgroup analysis of patients without UGIB.

  Variables                                Total Pts (n=118)   Moderate-large varices Pts (n=62)   No-Mild varices Pts (n=56)   P value     With varices Pts (n=68)   Without varices Pts (n=50)   P value
  ---------------------------------------- ------------------- ----------------------------------- ---------------------------- ----------- ------------------------- ---------------------------- -----------
  Sex (male/female)                        69/49               36/26                               33/23                        0.924       38/30                     31/19                        0.505
  Age (years)                              55.09±11.02         55.89±10.86                         54.21±11.24                  0.41        54.90±11.59               55.35±10.32                  0.828
  Etiology of liver diseases, n (%)                                                                                             **0.041**                                                          0.161
   Hepatitis B virus                       28 (23.7)           19 (30.6)                           9 (16.1)                                 19 (27.9)                 9 (18.0)                     
   Hepatitis C virus                       8 (6.8)             5 (8.1)                             3 (5.4)                                  6 (8.8)                   2 (4.0)                      
   Hepatitis B virus + Hepatitis C virus   1 (0.8)             1 (1.6)                             0 (0)                                    1 (1.5)                   0 (0)                        
   Alcohol                                 30 (25.4)           13 (21.0)                           17 (30.4)                                14 (20.6)                 16 (32.0)                    
   Hepatitis B virus + Alcohol             8 (6.8)             5 (8.1)                             3 (5.4)                                  5 (7.4)                   3 (6.0)                      
   Unknown                                 33 (28.0)           11 (17.7)                           22 (39.3)                                15 (22.1)                 18 (36.0)                    
   Others                                  10 (8.4)            8 (12.9)                            2 (3.6)                                  8 (11.8)                  2 (4)                        
  Ascites, n (%)                                                                                                                0.524                                                              0.172
   No                                      69 (58.5)           34 (54.8)                           35 (62.5)                                35 (51.5)                 34 (68.0)                    
   Mild                                    18 (15.3)           9 (14.5)                            9 (16.1)                                 13 (19.1)                 5 (10.0)                     
   Moderate to severe                      31 (26.3)           19 (30.6)                           12 (21.4)                                20 (29.4)                 11 (22.0)                    
  Hepatic encephalopathy, n (%)                                                                                                 0.34                                                               0.389
   No                                      117 (99.2)          61 (98.4)                           56 (100)                                 67 (98.5)                 50 (100)                     
   Grade I--II                             1 (0.8)             1 (1.6)                             0 (0)                                    1 (1.5)                   0 (0)                        
   Grade III--IV                           0 (0)               0 (0)                               0 (0)                                    0 (0)                     0 (0)                        
  Varices, n (%)                                                                                                                NA                                                                 NA
   No                                      50 (42.4)           0 (0)                               50 (89.3)                                0 (0)                     50 (100)                     
   Mild                                    6 (5.1)             0 (0)                               6 (10.7)                                 6 (8.8)                   0 (0)                        
   Moderate                                20 (16.9)           20(32.3)                            0 (0)                                    20 (29.4)                 0 (0)                        
   Severe                                  42 (35.6)           42 (67.7)                           0 (0)                                    42 (61.8)                 0 (0)                        
  Laboratory tests                                                                                                                                                                                 
   RBC                                     3.72±0.74           3.68±0.69                           3.76±0.79                    0.571       3.68±0.68                 3.78±0.82                    0.459
   Hb                                      116.69±25.85        115.45±25.58                        118.07±26.30                 0.585       115.12±25.03              118.84±27.03                 0.442
   WBC                                     4.26±2.29           3.94±2.39                           4.62±2.13                    0.106       3.91±2.34                 4.74±2.14                    0.051
   PLT                                     90.72±59.50         76.92±50.82                         106.00±64.91                 **0.007**   76.76±50.41               109.70±65.88                 **0.003**
   TBIL                                    31.02±36.80         30.39±21.34                         31.72±48.73                  0.845       30.15±20.97               32.20±51.28                  0.767
   DBIL                                    16.79±29.45         15.40±17.11                         18.33±38.93                  0.592       15.33±16.68               18.77±41.03                  0.533
   IBIL                                    14.19±9.92          14.94±8.40                          13.37±11.39                  0.394       14.75±8.35                13.44±11.78                  0.482
   ALB                                     35.30±6.13          34.04±5.84                          36.70±6.20                   **0.018**   33.97±5.98                37.11±5.92                   **0.006**
   ALT                                     55.03±122.69        45.95±46.68                         65.07±171.49                 0.4         44.84±44.79               68.88±181.27                 0.295
   AST                                     70.42±102.52        74.45±106.22                        65.95±99.02                  0.655       72.15±101.98              68.06±104.24                 0.832
   ALP                                     120.34±87.20        124.76±99.60                        115.46±71.59                 0.565       126.68±100.69             111.73±64.50                 0.36
   GGT                                     143.04±223.66       138.85±240.15                       147.68±205.94                0.832       142.13±238.07             144.28±204.81                0.959
   BUN                                     5.61±3.35           5.37±2.18                           5.89±4.29                    0.402       5.37±2.11                 5.94±4.52                    0.365
   Cr                                      64.85±55.02         58.35±27.04                         72.05±74.35                  0.178       57.34±26.15               75.06±78.15                  0.084
   PT                                      15.07±2.41          15.42±2.20                          14.67±2.58                   0.093       15.45±2.38                14.55±2.41                   **0.044**
   APTT                                    42.74±6.58          43.31±6.43                          42.10±6.74                   0.323       43.79±6.90                41.31±5.89                   **0.043**
   INR                                     1.19±0.25           1.23±0.24                           1.15±0.27                    0.094       1.23±0.25                 1.14±0.25                    **0.042**
  Child-Pugh class, n (%)                                                                                                       0.633                                                              0.211
   A                                       62 (52.5)           30 (48.4)                           32 (57.1)                                31 (45.6)                 31 (62.0)                    
   B                                       47 (39.8)           27 (43.5)                           20 (35.7)                                31 (45.6)                 16 (32.0)                    
   C                                       9 (7.6)             5 (8.1)                             4 (7.1)                                  6 (8.8)                   3 (6.0)                      
  Child-Pugh score                         6.69±1.73           6.89±1.81                           6.48±1.63                    0.206       6.96±1.86                 6.34±1.49                    0.056
  MELD score                               4.72±5.83           5.16±4.71                           4.24±6.88                    0.392       4.97±4.77                 4.39±7.07                    0.591
  APRI score                               3.13±5.13           3.69±6.44                           2.50±3.01                    0.209       3.58±6.18                 2.51±3.13                    0.261
  AAR score                                1.58±0.84           1.68±0.89                           1.48±0.79                    0.206       1.66±0.87                 1.48±0.80                    0.266
  FIB-4 score                              8.24±8.27           9.87±9.66                           6.45±5.98                    **0.024**   9.58±9.38                 6.42±6.10                    **0.04**
  FI score                                 −28.21±6.23         −26.81±5.83                         −29.76±6.25                  **0.01**    −26.74±5.98               −30.21±6.07                  **0.002**
  King score                               81.27±176.82        101.92±231.32                       58.40±78.43                  0.183       97.82±221.78              58.76±80.67                  0.237

AAR -- AST to ALT ratio; ALB -- albumin; ALP -- alkaline phosphatase; ALT -- alanine aminotransferase; APRI -- AST to platelets ratio index; APTT -- activated partial thromboplastin time; AST -- aspartate aminotransferase; AUC -- area under curve; BUN -- blood urea nitrogen; Cr -- creatinine; DBIL -- direct bilirubin; FI -- fibrosis index; FIB-4 -- fibrosis 4 index; GGT -- gamma-glutamyl transpeptidase; Hb -- hemoglobin; IBIL -- indirect bilirubin; INR -- international normalized ratio; MELD -- model for end-stage liver disease; NA -- not available; PLT -- platelet; PT -- prothrombin time; Pts -- patients; RBC -- red blood cell; TBIL -- total bilirubin; UGIB -- upper gastrointestinal bleeding; WBC -- white blood cell.

###### 

Subgroup analysis of patients without UGIB at Child-Pugh class A.

  Variables                                Total Pts (n=62)   Moderate-large varices Pts (n=30)   No-mild varices Pts (n=32)   P value     With warices Pts (n=31)   Without varices Pts (n=31)   P value
  ---------------------------------------- ------------------ ----------------------------------- ---------------------------- ----------- ------------------------- ---------------------------- -----------
  Sex (male/female)                        33/29              17/13                               16/16                        0.599       17/14                     16/15                        0.799
  Age (years)                              54.61±11.50        55.19±11.42                         54.06±11.74                  0.702       55.09±11.24               54.12±11.93                  0.741
  Etiology of liver diseases, n (%)                                                                                            0.159                                                              0.244
   Hepatitis B virus                       22 (35.5)          14 (46.7)                           8 (25.0)                                 14 (45.2)                 8 (25.8)                     
   Hepatitis C virus                       3 (4.8)            2 (6.7)                             1 (3.1)                                  2 (6.5)                   1 (3.2)                      
   Hepatitis B virus + Hepatitis C virus   0 (0)              0 (0)                               0 (0)                                    0 (0)                     0 (0)                        
   Alcohol                                 11 (17.7)          4 (13.3)                            7 (21.9)                                 4 (12.9)                  7 (22.6)                     
   Hepatitis B virus + Alcohol             3 (4.8)            2 (6.7)                             1 (3.1)                                  2 (6.5)                   1 (3.2)                      
   Unknown                                 20 (32.3)          6 (20.0)                            14 (43.8)                                7 (22.6)                  13 (41.9)                    
   Others                                  3 (4.8)            2 (6.7)                             1 (3.1)                                  2 (6.5)                   1 (3.2)                      
  Ascites, n (%)                                                                                                               0.947                                                              1
   No                                      58 (93.5)          28 (93.3)                           30 (93.8)                                29 (93.5)                 29 (93.5)                    
   Mild                                    4 (6.5)            2 (6.7)                             2 (6.3)                                  2 (6.5)                   2 (6.5)                      
   Moderate to severe                      0 (0)              0 (0)                               0 (0)                                    0 (0)                     0 (0)                        
  Hepatic encephalopathy, n (%)                                                                                                NA                                                                 NA
   No                                      62 (100)           30 (100)                            32 (100)                                 31 (100)                  31 (100)                     
   Grade I--II                             0 (0)              0 (0)                               0 (0)                                    0 (0)                     0 (0)                        
   Grade III--IV                           0 (0)              0 (0)                               0 (0)                                    0 (0)                     0 (0)                        
  Varices, n (%)                                                                                                               NA                                                                 NA
   No                                      31 (50.0)          0 (0)                               31 (96.9)                                0 (0)                     31 (100)                     
   Mild                                    1 (1.6)            0 (0)                               1 (3.1)                                  3 (3.2)                   0 (0)                        
   Moderate                                8 (12.9)           8 (26.7)                            0 (0)                                    8 (25.8)                  0 (0)                        
   Severe                                  22 (35.5)          22 (73.3)                           0 (0)                                    22 (71.0)                 0 (0)                        
  Laboratory tests                                                                                                                                                                                
   RBC                                     3.95±0.71          3.40±0.57                           3.90±0.83                    0.588       3.99±0.56                 3.91±0.84                    0.637
   Hb                                      122.03±25.39       123.23±23.38                        120.91±27.47                 0.722       123.00±23.02              121.06±27.91                 0.767
   WBC                                     3.82±1.52          3.37±1.10                           4.24±1.75                    **0.023**   3.38±1.08                 4.26±1.78                    **0.022**
   PLT                                     87.34±50.03        76.10±44.14                         97.88±53.52                  0.087       76.48±43.45               98.19±54.38                  0.088
   TBIL                                    19.43±9.53         20.66±7.61                          18.27±11.04                  0.327       20.57±7.50                18.29±11.22                  0.35
   DBIL                                    7.66±3.93          7.93±3.25                           7.34±4.52                    0.56        7.88±3.20                 7.37±4.59                    0.614
   IBIL                                    11.72±5.90         12.63±4.78                          10.87±6.75                   0.242       12.53±4.74                10.92±6.85                   0.287
   ALB                                     38.68±4.62         38.09±4.44                          39.23±4.79                   0.338       38.12±4.37                39.23±4.87                   0.347
   ALT                                     45.19±50.60        46.07±48.51                         44.38±53.25                  0.897       46.00±47.70               44.39±54.13                  0.901
   AST                                     51.81±51.21        56.17±61.74                         47.72±39.50                  0.521       55.61±60.78               48.00±40.12                  0.563
   ALP                                     100.61±70.72       109.89±94.03                        91.92±37.51                  0.321       113.83±95.02              87.40±27.91                  0.142
   GGT                                     104.42±177.76      89.47±144.00                        118.44±205.82                0.526       105.42±167.13             103.42±190.57                0.965
   BUN                                     5.10±2.34          5.22±1.30                           4.99±3.03                    0.704       5.26±1.30                 4.94±3.07                    0.594
   Cr                                      60.24±49.09        54.74±10.69                         65.39±67.66                  0.398       54.95±10.57               65.53±68.78                  0.4
   PT                                      14.11±1.55         14.51±1.62                          13.74±1.42                   **0.05**    14.42±1.67                13.81±1.39                   0.119
   APTT                                    40.95±5.49         41.21±5.67                          40.70±5.39                   0.718       41.32±5.61                40.58±5.43                   0.6
   INR                                     1.09±0.15          1.14±0.16                           1.05±0.14                    **0.036**   1.13±0.17                 1.06±0.14                    0.089
  Child-Pugh score                         5.35±0.48          5.33±0.48                           5.38±0.49                    0.737       5.32±0.48                 5.39±0.50                    0.603
  MELD score                               2.42±3.99          3.13±3.17                           1.76±4.58                    0.179       3.06±3.14                 1.78±4.66                    0.21
  APRI score                               2.29±2.75          2.44±2.73                           2.15±2.80                    0.68        2.40±2.69                 2.18±2.84                    0.75
  AAR score                                1.29±0.44          1.29±0.36                           1.29±0.50                    0.979       1.28±0.36                 1.30±0.50                    0.835
  FIB-4 score                              6.26±5.03          6.84±4.46                           5.71±5.53                    0.382       6.73±4.42                 5.79±5.61                    0.462
  FI score                                 −31.55±4.68        −30.85±4.44                         −32.20±4.87                  0.258       −30.88±4.37               −32.21±4.95                  0.266
  King score                               51.28±70.67        57.61±75.38                         45.34±66.61                  0.499       56.39±74.42               44.17±67.55                  0.573

AAR -- AST to ALT ratio; ALB -- albumin; ALP -- alkaline phosphatase; ALT -- alanine aminotransferase; APRI -- AST to platelets ratio index; APTT -- activated partial thromboplastin time; AST -- aspartate aminotransferase; AUC -- area under curve; BUN -- blood urea nitrogen; Cr -- creatinine; DBIL -- direct bilirubin; FI -- fibrosis index; FIB-4 -- fibrosis 4 index; GGT -- gamma-glutamyl transpeptidase; Hb -- hemoglobin; IBIL -- indirect bilirubin; INR -- international normalized ratio; MELD -- model for end-stage liver disease; NA -- not available; PLT -- platelet; PT -- prothrombin time; Pts -- patients; RBC -- red blood cell; TBIL -- total bilirubin; UGIB -- upper gastrointestinal bleeding; WBC -- white blood cell.

###### 

Subgroup analysis patients without UGIB at Child-Pugh class B and C.

  Variables                                Total Pts (n=56)   Moderate-large varices Pts (n=32)   No-mild varices Pts (n=24)   P value     With varices Pts (n=37)   Without varices Pts (n=19)   P value
  ---------------------------------------- ------------------ ----------------------------------- ---------------------------- ----------- ------------------------- ---------------------------- -----------
  Sex (male/female)                        36/20              19/13                               17/7                         0.376       21/16                     15/4                         0.101
  Age (years)                              55.63±10.55        56.55±10.45                         54.41±10.78                  0.457       54.74±12.02               57.36±6.79                   0.383
  Etiology of liver diseases, n (%)                                                                                            0.355                                                              0.617
   Hepatitis B virus                       6 (10.7)           5 (15.6)                            1 (4.2)                                  5 (13.5)                  1 (5.3)                      
   Hepatitis C virus                       5 (8.9)            3 (9.4)                             2 (8.3)                                  4 (10.8)                  1 (5.3)                      
   Hepatitis B virus + Hepatitis C virus   1 (1.8)            1 (3.1)                             0 (0)                                    1 (2.7)                   0 (0)                        
   Alcohol                                 19 (33.9)          9 (28.1)                            10 (41.7)                                10 (27.0)                 9 (47.4)                     
   Hepatitis B virus + Alcohol             5 (8.9)            3 (9.4)                             2 (8.3)                                  3 (8.1)                   2 (10.5)                     
   Unknown                                 13 (23.2)          5 (15.6)                            8 (33.3)                                 8 (21.6)                  5 (26.3)                     
   Others                                  7 (12.5)           6 (18.8)                            1 (4.2)                                  6 (16.2)                  1 (5.3)                      
  Ascites, n (%)                                                                                                               0.763                                                              0.436
   No                                      11 (19.6)          6 (18.8)                            5 (20.8)                                 6 (16.2)                  5 (26.3)                     
   Mild                                    14 (25.0)          7 (21.9)                            7 (29.2)                                 11 (29.7)                 3 (15.8)                     
   Moderate to severe                      31 (55.4)          19 (59.4)                           12 (50.0)                                20 (54.1)                 11 (57.9)                    
  Hepatic encephalopathy, n (%)                                                                                                0.382                                                              0.47
   No                                      55 (98.2)          31 (96.9)                           24 (100)                                 36 (97.3)                 19 (100)                     
   Grade I--II                             1 (1.8)            1 (3.1)                             0 (0)                                    1 (2.7)                   0 (0)                        
   Grade III--IV                           0 (0)              0 (0)                               0 (0)                                    0 (0)                     0 (0)                        
  Varices, n (%)                                                                                                               NA                                                                 NA
   No                                      19 (33.9)          0 (0)                               19 (79.2)                                0 (0)                     19 (100)                     
   Mild                                    5 (8.9)            0 (0)                               5 (20.8)                                 5 (13.5)                  0 (0)                        
   Moderate                                12 (21.4)          12 (37.5)                           0 (0)                                    12 (32.4)                 0 (0)                        
   Severe                                  20 (35.7)          20 (62.5)                           0 (0)                                    20 (54.1)                 0 (0)                        
  Laboratory tests                                                                                                                                                                                
   RBC                                     3.47±0.70          3.38±0.68                           3.57±0.72                    0.321       3.41±0.66                 3.57±0.76                    0.418
   Hb                                      110.79±25.26       108.16±25.74                        114.29±24.72                 0.373       108.51±25.02              115.21±25.83                 0.352
   WBC                                     4.76±2.84          4.48±3.08                           5.13±2.50                    0.398       4.36±2.97                 5.53±2.48                    0.147
   PLT                                     94.46±68.76        77.69±57.08                         116.83±77.46                 **0.034**   77.00±56.17               128.47±79.29                 **0.007**
   TBIL                                    43.86±49.60        39.50±25.78                         49.66±70.19                  0.453       38.18±25.02               54.90±77.92                  0.236
   DBIL                                    26.93±40.35        22.41±21.48                         32.97±56.61                  0.337       21.58±20.53               37.37±62.91                  0.168
   IBIL                                    16.93±14.50        17.10±10.37                         16.71±15.11                  0.911       16.61±10.16               17.56±16.44                  0.789
   ALB                                     31.57±5.42         30.24±4.23                          33.34±6.35                   **0.033**   30.50±4.86                33.65±5.96                   **0.038**
   ALT                                     65.91±170.15       45.84±45.67                         92.67±255.18                 0.313       43.86±42.84               108.84±286.09                0.178
   AST                                     91.02±136.48       91.59±134.20                        90.25±142.36                 0.971       86.00±125.87              100.79±158.35                0.705
   ALP                                     142.19±98.51       138.69±104.10                       146.84±92.52                 0.762       137.44±105.29             151.43±85.69                 0.619
   GGT                                     185.80±260.43      185.16±299.19                       186.67±203.82                0.983       172.89±282.97             210.95±214.69                0.609
   BUN                                     6.18±4.14          5.50±2.78                           7.08±5.39                    0.161       5.46±2.62                 7.57±5.96                    0.072
   Cr                                      69.96±60.95        61.72±36.15                         80.93±83.08                  0.247       59.35±34.22               90.62±91.26                  0.069
   PT                                      16.12±2.74         16.27±2.36                          15.92±3.22                   0.638       16.31±2.51                15.75±3.18                   0.479
   APTT                                    44.72±7.15         45.28±6.57                          43.98±7.94                   0.506       45.85±7.26                42.51±6.55                   0.097
   INR                                     1.30±0.29          1.32±0.27                           1.28±0.33                    0.651       1.32±0.28                 1.27±0.33                    0.489
  Child-Pugh score                         8.18±1.36          8.34±1.31                           7.96±1.43                    0.299       8.32±1.42                 7.89±1.24                    0.268
  MELD score                               7.27±6.49          7.07±5.15                           7.54±8.06                    0.79        6.57±5.32                 8.63±8.32                    0.265
  APRI score                               4.05±6.77          4.86±8.48                           2.97±3.28                    0.305       4.57±7.93                 3.04±3.57                    0.429
  AAR score                                1.90±1.05          2.03±1.08                           1.73±1.01                    0.286       1.97±1.04                 1.77±1.09                    0.502
  FIB-4 score                              10.44±10.40        12.70±12.16                         7.42±6.53                    0.06        11.97±11.60               7.46±6.87                    0.126
  FI score                                 −24.51±5.65        −23.02±4.23                         −26.51±6.71                  **0.021**   −23.27±4.84               −26.94±6.43                  **0.02**
  King score                               114.47±242.56      143.47±310.32                       75.81±90.42                  0.306       132.53±290.18             79.31±96.92                  0.442

AAR -- AST to ALT ratio; ALB -- albumin; ALP -- alkaline phosphatase; ALT -- alanine aminotransferase; APRI -- AST to platelets ratio index; APTT -- activated partial thromboplastin time; AST -- aspartate aminotransferase; AUC -- area under curve; BUN -- blood urea nitrogen; Cr -- creatinine; DBIL -- direct bilirubin; FI -- fibrosis index; FIB-4 -- fibrosis 4 index; GGT -- gamma-glutamyl transpeptidase; Hb -- hemoglobin; IBIL -- indirect bilirubin; INR -- international normalized ratio; MELD -- model for end-stage liver disease; NA -- not available; PLT -- platelet; PT -- prothrombin time; Pts -- patients; RBC -- red blood cell; TBIL -- total bilirubin; UGIB -- upper gastrointestinal bleeding; WBC -- white blood cell.

###### 

Subgroup analysis of patients without UGIB or splenectomy.

  Variables                                Total Pts (n=112)   Moderate-large varices Pts (n=57)   No-mild varices Pts (n=55)   P value     With varices Pts (n=62)   Without varices Pts (n=50)   P value
  ---------------------------------------- ------------------- ----------------------------------- ---------------------------- ----------- ------------------------- ---------------------------- ------------
  Sex (male/female)                        66/46               33/24                               33/22                        0.821       35/27                     31/19                        0.553
  Age (years)                              55.19±10.50         55.49±10.91                         54.88±10.15                  0.757       55.06±10.73               55.35±10.32                  0.885
  Etiology of liver diseases, n (%)                                                                                             **0.047**                                                          0.149
   Hepatitis B virus                       28 (25.0)           19 (33.3)                           9 (16.4)                                 19 (30.6)                 9 (18.0)                     
   Hepatitis C virus                       6 (5.4)             3 (5.3)                             3 (5.5)                                  4 (6.5)                   2 (4.0)                      
   Hepatitis B virus + Hepatitis C virus   1 (0.9)             1 (1.8)                             0 (0)                                    1 (1.6)                   0 (0)                        
   Alcohol                                 28 (25.0)           11 (19.3)                           17 (30.9)                                12 (19.4)                 16 (32.0)                    
   Hepatitis B virus + Alcohol             7 (6.3)             4 (7.0)                             3 (5.5)                                  4 (6.5)                   3 (6.0)                      
   Unknown                                 32 (28.6)           11 (19.3)                           21 (38.2)                                14 (22.6)                 18 (36.0)                    
   Others                                  10 (9.0)            8 (14.0)                            2 (3.6)                                  8 (12.9)                  2 (4.0)                      
  Ascites, n (%)                                                                                                                0.495                                                              0.202
   No                                      66 (58.9)           31 (54.4)                           35 (63.6)                                32 (51.6)                 34 (68.0)                    
   Mild                                    16 (14.3)           8 (14.0)                            8 (14.5)                                 11 (17.7)                 5 (10.0)                     
   Moderate to severe                      30 (26.8)           18 (31.6)                           12 (21.8)                                19 (30.6)                 11 (22.0)                    
  Hepatic encephalopathy, n (%)                                                                                                 0.324                                                              0.367
   No                                      111 (99.1)          56 (98.2)                           55 (100)                                 61 (98.4)                 50 (100)                     
   Grade I--II                             1 (0.9)             1 (1.8)                             0 (0)                                    1 (1.6)                   0 (0)                        
   Grade III--IV                           0                   0 (0)                               0 (0)                                    0 (0)                     0 (0)                        
  Varices, n (%)                                                                                                                NA                                                                 NA
   No                                      50 (44.6)           0 (0)                               50 (90.9)                                0 (0)                     50 (100)                     
   Mild                                    5 (4.5)             0 (0)                               5 (9.1)                                  5 (8.1)                   0 (0)                        
   Moderate                                17 (15.2)           17 (29.8)                           0 (0)                                    17 (27.4)                 0 (0)                        
   Severe                                  40 (35.7)           40 (70.2)                           0 (0)                                    40 (64.5)                 0 (0)                        
  Laboratory tests                                                                                                                                                                                 
   RBC                                     3,72±0.75           3.67±0.70                           3.77±0.80                    0.511       3.67±0.69                 3.78±0.82                    0.452
   Hb                                      116.52±25.46        114.95±24.51                        118.15±26.54                 0.509       114.65±24.19              118.84±27.03                 0.388
   WBC                                     4.22±2.32           3.88±2.47                           4.58±2.12                    0.111       3.80±2.39                 4.74±2.14                    **0.032**
   PLT                                     86.51±56.75         68.74±40.66                         104.93±65.01                 **0.001**   67.81±39.71               109.70±65.88                 **﹤0.01**
   TBIL                                    31.39±37.63         30.93±21.79                         31.87±49.17                  0.895       30.74±21.52               32.20±51.28                  0.839
   DBIL                                    17.21±30.15         15.98±17.66                         18.49±39.27                  0.662       15.95±17.29               18.77±41.03                  0.625
   IBIL                                    14.14±10.01         14.89±8.38                          13.36±11.49                  0.42        14.70±8.39                13.44±11.78                  0.509
   ALB                                     35.33±6.03          33.82±5.63                          36.89±6.09                   **0.007**   33.89±5.78                37.11±5.92                   **0.005**
   ALT                                     54.96±125.56        44.88±46.45                         65.42±173.05                 0.389       43.74±44.76               68.88±181.27                 0.294
   AST                                     70.61±104.86        75.81±110.16                        62.22±99.78                  0.595       72.66±106.15              68.06±104.24                 0.819
   ALP                                     120.29±85.90        129.11±102.22                       111.15±64.53                 0.271       127.19±99.89              111.73±64.50                 0.346
   GGT                                     145.40±228.06       146.47±249.14                       144.29±206.25                0.96        146.31±246.88             144.28±204.81                0.963
   BUN                                     5.62±3.42           5.40±2.24                           5.86±4.33                    0.476       5.37±2.16                 5.94±4.52                    0.379
   Cr                                      65.27±56.43         58.48±28.12                         72.31±75.01                  0.196       57.37±27.32               75.06±78.15                  0.099
   PT                                      15.03±2.43          15.37±2.23                          14.68±2.60                   0.136       15.42±2.39                14.55±2.41                   0.057
   APTT                                    42.46±6.48          42.97±6.26                          41.97±6.72                   0.416       43.41±6.82                41.31±5.89                   0.088
   INR                                     1.19±0.25           1.22±0.23                           1.15±0.27                    0.153       1.23±0.25                 1.14±0.25                    0.06
  Child-Pugh class, n (%)                                                                                                       0.478                                                              0.206
   A                                       59 (52.7)           27 (47.4)                           32 (58.2)                                28 (45.2)                 31 (62.0)                    
   B                                       45 (40.2)           26 (45.6)                           19 (34.5)                                29 (46.8)                 16 (32.0)                    
   C                                       8 (7.1)             4 (7.0)                             4 (7.3)                                  5 (8.1)                   3 (6.0)                      
  Child-Pugh score                         6.69±1.72           6.91±1.79                           6.45±1.63                    0.16        6.97±1.85                 6.34±1.49                    0.054
  MELD score                               4.69±5.98           5.13±4.90                           4.24±6.94                    0.432       4.94±4.97                 4.39±7.07                    0.627
  APRI score                               3.22±5.24           3.90±6.68                           2.51±3.04                    0.163       3.79±6.43                 2.51±3.13                    0.198
  AAR score                                1.59±0.85           1.72±0.91                           1.46±0.78                    0.119       1.68±0.89                 1.48±0.80                    0.219
  FIB-4 score                              8.51±8.38           10.42±9.85                          6.53±6.00                    **0.014**   10.19±9.57                6.42±6.10                    **0.017**
  FI score                                 −28.20±6.15         −26.51±5.59                         −29.94±6.26                  **0.003**   −26.57±5.76               −30.21±6.07                  **0.002**
  King score                               83.77±180.99        107.44±240.35                       59.24±78.90                  0.16        103.95±231.20             58.76±80.67                  0.19

AAR -- AST to ALT ratio; ALB -- albumin; ALP -- alkaline phosphatase; ALT -- alanine aminotransferase; APRI -- AST to platelets ratio index; APTT -- activated partial thromboplastin time; AST -- aspartate aminotransferase; AUC -- area under curve; BUN -- blood urea nitrogen; Cr -- creatinine; DBIL -- direct bilirubin; FI -- fibrosis index; FIB-4 -- fibrosis 4 index; GGT -- gamma-glutamyl transpeptidase; Hb -- hemoglobin; IBIL -- indirect bilirubin; INR -- international normalized ratio; MELD -- model for end-stage liver disease; NA -- not available; PLT -- platelet; PT -- prothrombin time; Pts -- patients; RBC -- red blood cell; TBIL -- total bilirubin; UGIB -- upper gastrointestinal bleeding; WBC -- white blood cell.
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